NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2013 Financial Results and a Clinical/Business Update

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., Aug. 1, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE:NBY), an advanced clinical-stage biotechnology company focused on the topical, anti-infective market, today reported second quarter 2013 financial results and provided a clinical update.

Help employers find you! Check out all the jobs and post your resume.

Back to news